Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03749499 · ClinicalTrials.gov registry record · NA

Targeting of UnControlled Hypertension in Emergency Department

A NA study of Hypertension and Cardiovascular Diseases, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
574
Enrollment target
1
Study location

NCT03749499: Completed NA study of Hypertension and Cardiovascular Diseases, sponsored by University of Illinois at Chicago.

NCT03749499 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by University of Illinois at Chicago. The registered enrollment target is 574 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03749499, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
574 participants
Enrollment target
1
Study location

Study Summary

The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagement and early risk assessment/stratification is a cost-effective, feasible innovation to help close health disparity gaps in HTN. This proposal involves a two-arm randomized controlled trial of up to 770 patients from the Emergency Department at University of Illinois Hospital with elevated blood pressure (BP). The primary objective is to determine the effectiveness of an emergency department-initiated Educational and Empowerment (E2) intervention with a Post Acute Care Hypertension Consultation (PACHT-c) intervention (arm 2) on the primary outcome of mean systolic blood pressure (SBP) differences between the two trial arms at 6-months post intervention. Secondary objectives include evaluating the effectiveness of this ED education and empowerment intervention on mean SBP and diastolic blood pressure (DBP) differences at 3-months, and mean DBP differences at 6-months.

Primary Outcome

Blood pressure will be collected at two time points (baseline and 6 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Interventions

  • OTHER HTN Educational Video
  • OTHER Visual Echocardiogram Image Clips
  • OTHER Mobile Health and Remote BP monitoring
  • OTHER Post-Acute Care HTN Transition consultation (PACHT-c)

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 574 participants
Start Date 2019-02-19
Est. Completion 2023-03-31
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT03749499 record still lists

NCT03749499 is an interventional study that assigns participants to a tested intervention. The registered 574 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 4 interventions - of which HTN Educational Video is the first listed.

NCT03749499 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03749499 about?

NCT03749499 is a clinical study titled "Targeting of UnControlled Hypertension in Emergency Department". The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagement and early risk assessment/stratification is a cost-effective, feasible innovation to help close he...

What is the current status of trial NCT03749499?

This trial is currently completed. It is a NA study. The enrollment target is 574 participants. The study started on 2019-02-19. Estimated completion is 2023-03-31.

What conditions does trial NCT03749499 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases.

What interventions are being tested in trial NCT03749499?

The interventions under investigation include: HTN Educational Video (OTHER), Visual Echocardiogram Image Clips (OTHER), Mobile Health and Remote BP monitoring (OTHER), Post-Acute Care HTN Transition consultation (PACHT-c) (OTHER).

Who is sponsoring clinical trial NCT03749499?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03749499 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03749499's enrollment target sits among peer trials

574 103rd of 470 higher than 368 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07349537 · 574 participants · Phase 1

    Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • NCT02610439 · 575 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

  • NCT05919264 · 575 participants · Phase 1

    FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • NCT06583148 · 575 participants · NA

    A Smoke-Free Home Intervention in Tribal Communities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03749499, the US trial registry maintained by the National Library of Medicine. NCT03749499 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.